Today is the first day of the fourth exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works reports second quarter 2025

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 3 of 11

Bio-Works Receives SEK 5.5 Million Order from Global Pharmaceutical Company

Technical Sales Manager

Bio-Works Technologies develops high-quality chromatography products to support biopharmaceutical development. They are seeking a dedicated Technical Sales Manager to drive business growth in North America by identifying new opportunities, developing customer relationships, and closing sales deals.

Sign up with Google

Sign in with Google